![](https://investorshub.advfn.com/uicon/607320.png?cb=1602587228)
Monday, November 09, 2020 12:23:45 PM
Go Leo & IPIX!
The "90% efficacy" claim is troubling. Based on what? This is a misleading claim. Because they are not releasing details, what seems to be able to be gleaned from what they are saying is that 90% of the cases of COVID-19 were in members of the control group. However, there are only 94 cases of COVID out of the 44,000 volunteers, and this, after only two months after vaccination.
Also, Pfizer's vaccine requires two doses, and the vaccine has to be stored and transported at extremely low temperatures. What are the chances that the vaccine will always be handled properly so that it is effective?
And, what are the chances that this vaccine is indeed safe and does not have longer-term side effects? Just as a recent example, the initial shingles vaccine was widely hailed as a safe and effective vaccine. Then, after a lot of people got dosed -- whoops, guess what, it is NOT safe and in some people TRIGGERED cases of shingles. (Please note: that vaccine has been withdrawn and the current one is safer -- supposedly.)
There have been many other cases of vaccines that appeared to be safe which turned out to have bad side effects over the longer term, when given to a very large population. Swine flu vaccine, anyone?
Also, they are saying that they will have enough vaccine to dose 15-20 million people in the next year. Even if this vaccine is safe and effective, and does not cause long-term side effects -- 15-20 million people vaccinated with even an optimistic 90% efficacy will NOT get the pandemic under control.
TREATMENTS will. And if you or a family member are among those who get COVID in the next year, you're going to be mighty grateful if there are good treatments available -- like, for instance, Brilacidin.
Brilacidin In a human lung cell line infected by SARS-CoV-2, Brilacidin achieved a high Selectivity Index rating of 426.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM